Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2020-05-19 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东减持股份的预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a pre-disclosure announcement regarding a shareholder's plan to reduce their holdings in the company. It details the shareholder's identity, the number and percentage of shares held, the planned reduction amount, timing, and method of sale, as well as compliance with regulatory requirements. The document references specific regulations governing shareholder share reduction disclosures and is clearly an announcement of a planned shareholding reduction by a major shareholder. It does not contain financial statements, audit information, or management discussion, nor is it a report or transcript. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2020-05-19 Chinese
关于持股5%以上股东持股比例变动达到1%的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a change in shareholding by a shareholder holding more than 5% of the company's shares, specifically a change of at least 1%. It details the shareholder's name, shareholding before and after the change, and the method of change. This matches the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or other types of filings. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and content support this classification with high confidence.
2020-05-19 Chinese
首次公开发行前已发行股份上市流通提示性公告
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行前已发行股份上市流通提示性公告" which translates to "Announcement on the Listing and Circulation of Shares Issued Before the Initial Public Offering." It details the unlocking of restricted shares, the number of shares becoming tradable, shareholder commitments, and regulatory compliance. It references regulatory approvals and stock exchange rules, but it is not a financial report or earnings release. The document is an official announcement regarding share circulation and compliance with listing rules, specifically about the lifting of share restrictions and the resulting share availability for trading. It does not contain financial statements or management discussion but focuses on shareholding and listing status updates. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement that does not fit into more specific categories like capital changes or major shareholding notifications. The document length is about 4700 characters, which is substantive and not a mere brief notice, but it is not a financial report or capital structure change announcement per se. Therefore, the best classification is Regulatory Filings (RNS).
2020-05-12 Chinese
广发证券股份有限公司关于公司首次公开发行前股份解除限售并上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the lifting of share restrictions and the listing circulation of shares before the initial public offering (IPO) of Yantai Zhenghai Biotechnology Co., Ltd. It references regulatory approvals, shareholding structures, shareholder commitments, and compliance with relevant securities laws and stock exchange rules. The document is not a financial report, earnings release, or management discussion but rather a formal regulatory compliance and verification statement related to share unlocking and circulation post-IPO. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and verification announcement that does not constitute a financial report or other specific filing type.
2020-05-12 Chinese
关于全资子公司注册地址变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the registered address of a wholly-owned subsidiary of the company. It provides details about the new address, business license information, and confirms the completion of the address change. There is no financial data, no mention of financial results, no regulatory certifications, or meeting-related materials. This is a corporate announcement about a subsidiary's address change, which does not fit into financial reports, governance changes, or other specific categories. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2020-05-11 Chinese
第二届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is titled as a '监事会决议公告' which translates to 'Supervisory Board Resolution Announcement'. It details the resolution passed by the supervisory board regarding the company's 2020 first quarter report. The document states that the supervisory board has reviewed and approved the 2020 Q1 report, confirming its compliance with laws and regulations and the accuracy of its content. The document is short (725 characters) and serves as an announcement of the supervisory board's approval of the quarterly report rather than the report itself. Therefore, it is not the Interim/Quarterly Report (IR) itself but an announcement related to it. Given the nature of the document as an official announcement of a board resolution, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2020-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.